APA (7th ed.) Citation

Ma, Y., Lu, Y., Wu, Q., Lou, Y., Yang, M., Xu, J., . . . Yan, X. (2022). Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia. Journal of Hematology & Oncology, 15(1), 1. https://doi.org/10.1186/s13045-022-01368-3

Chicago Style (17th ed.) Citation

Ma, Ya-Fang, et al. "Oral Arsenic and Retinoic Acid for High-risk Acute Promyelocytic Leukemia." Journal of Hematology & Oncology 15, no. 1 (2022): 1. https://doi.org/10.1186/s13045-022-01368-3.

MLA (9th ed.) Citation

Ma, Ya-Fang, et al. "Oral Arsenic and Retinoic Acid for High-risk Acute Promyelocytic Leukemia." Journal of Hematology & Oncology, vol. 15, no. 1, 2022, p. 1, https://doi.org/10.1186/s13045-022-01368-3.